Exam 3: Dementia/Delirium Flashcards

1
Q

Define dementia

A

A general term for the impaired ability to remember, think, or make decisions that interferes with doing everyday activities.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what areas are affected by dementia and delirium?

A

-2) temporal lobe: Association area: short term memory, equilibrium, emotion

-13) frontal lobe: High mental functions: concentration, planning, judgement, emotional expression, creativity, inhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what does the reticular activating system maintain?

A

– maintains wakefulness

**in dementia and delirium–>RAS is sometimes off kilter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are neurons? and how do they communicate?

A

they are functional cells of the CNS that send and receives information, they are supported by glial cells

  • long axons synapses with another neuron and communication goes back and forth between neurons along the axons
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the three types of glial cells? and its functions

A

-microglial: phagocytes–cells that go through the CNS and check for abnormalities and correct them

-astrocytes: blood vessel support and communication

  • oligodenocytes: myelin sheath production
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are irreversible dementia?

A
  • alzheimer
  • frontotemporal
  • Lewy body
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are most common reversible dementia?

A

-Alcoholism (chronic)

-Medications: Anticholinergics and antihistamines (typically used inappropriately in older adults)

-Metabolic diseases: Hypothyroidism and hepatic encephalopathy (complication of etoh)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the mechanisms of Irreversible degenerative dementia?

A
  • Abnormal proteins that damage neurons and/or neuronal connections leading to neuronal cell death

**the global pathophysiology for dementia of the irreversible type is abnormal protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

molecular mechanism of Alzheimer

A
  • amyloid beta protein
  • phosphorylated tau protein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

pathology of Alzheimer

A

amyloid plaques, neurofibrillary tangles, neuronal and synaptic loss in the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

molecular mechanism of dementia with Lewy bodies

A

alpha-synuclein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

pathology of dementia with Lewy bodies

A

alpha-synuclein inclusions (Lewy bodies)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

molecular mechanism of behavioral variant frontotemporal dementia

A

microtubule-associated protein tau (MAPT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

pathology of frontotemporal dementia (3)

A
  • tau inclusions
  • pick bodies
  • neurofibrillary tangles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the most common dementias associated with?

A

Genetic risks exist but the most common dementias are associated with susceptible genes and multifactorial contributions.

Here’s the expression: “The genes load the gun and the environment and lifestyle pull the trigger.” The truly horrific, early onset, causal gene dementias typically involve an autosomal dominant allele and clear familial transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

manifestations of dementia

A

classics are insidious onset (core feature) and progressive decline of cognition, memory, and ability to care for self.

insidious onset–>means slow, its gradual, it sort of sneaks up on you

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what are the screening test for dementia? (2)

A
  • mini mental status exam
    -montreal cognitive assessment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Abnormal proteins associated with Alzheimer disease

A

i. Beta amyloid plaque: Amyloid precursor protein (APP), a cell wall glycoprotein, is cleaved by enzymes → beta amyloid protein fragment. Fragments aggregate outside the neuron producing amyloid plaque.
ii. Neurofibrillary tau tangles: The axon is composed of microtubules that send signals from one neuron to another. Tau protein makes up the structure of the microtubule. Tau protein structure altered, microtubules disrupted, tau collects inside the neuron.
iii. Results on beta amyloid and tau: Impaired cell to cell communication and eventually cell death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is the pathophysiology of alzheimer’s dementia?

A

Abnormal proteins damage the 1. neuron cell body and 2. Axons. Neuron to neuron signaling and neuron death occurs.

20
Q

what can occur when more neurons die throughout the brain?

A

people may express:
- memory loss
- impaired decision making
- language problems

21
Q

what is used to diagnose Alzheimer?

A

a. History, physical exam, blood work, genetic testing in people with family history, and memory (MMSE or MOCA)/psychiatric testing to rule out reversible causes of dementia.

b. Diagnostic and Statistical Manual V (DSM-V): Core characteristics insidious onset and gradual decline AND cognitive impairment in two of the following domains:

  • MRI: brain atrophy, sulci (furrows) widening, gyri (folds) shrinking and ventricle enlarging
    -Positron emitting tomography (PET) using tracers to detect amyloid plaque and neurofibrillary tau tangles. Required to qualify for newer drugs that clear amyloid plaque (Aducanumab (Aduhelm)).
22
Q

lis the five Diagnostic and Statistical Manual V (DSM-V) domain for dementia

A

i. Acquiring and remembering new information: short term memory loss (first impairment)–temporal lobe
ii. Reasoning, judgement, and complex thinking–frontal lobe
iii. Visual special perception
iv. Language use and expression
v. Personality or behavior

23
Q

what area of the brain does Alzheimer affect?

A
  • changes start in the temporal lobe/hippocampus (memory) and progress toe involve the entire cerebral cortex
24
Q

biomarks for Alzheimers disease (2)

A

i. Cerebrospinal fluid: Amyloid beta and tau proteins.
ii. Plasma: Still in investigative stage.

25
Q

usual age of onset for Alzheimers disease

A

~ 60 years old

**On average, individual will live 4-8 years from diagnosis (~ 60) to death (5th leading cause of death for those 65+). Sometimes termed “the long goodbye.”

26
Q

does mild cognitive impairment disease mean someone has Alzheimers?

A

No
Mild cognitive impairment: Changes in thinking that are recognized by patient and family and may represent a precursor to Alzheimer disease or natural effect of old age

27
Q

manifestions: Alzheimer disease: Mild

A

Individual able to function (work, drive, social interaction) and is aware of difficulties with:
i. recalling recently learned material (three-word recall), name recall
ii. word finding
iii. losing or misplacing items
iv. task completion

28
Q

manifestations: Alzheimer disease: Moderate

A

Progressive worsening of symptoms + personality changes. Needs help with ADLs.
i. forgetful about personal history
ii. disoriented and day/night pattern disruption, wandering
iii. behavioral and psychological changes – fearful, suspicious
iv. assistance needed for self-care: hygiene, clothing, toileting

29
Q

manifestations: Alzheimer disease: Severe.

A

Unable to care for self.
i. Loss of awareness of experiences/surroundings/family
ii. Decreased ability to communicate -> non-verbal
iii. Physical motor abilities lost: Completely dependent, bedridden, impaired swallowing ( can lead to pna, which is common cause of death)

30
Q

pathophysiology of Lewy body dementia

A

Alpha synuclein protein cluster together forming Lewy bodies. Lewy bodies damage dopamine mediated cell-to-cell communication especially in the cerebral cortex, amygdala (mood), and hippocampus (memory and learning).

31
Q

what are the diagnosis for Lewy body dementia?

A

a. History and physical: Similar to Alzheimer disease.
b. Single Photon emission computed tomography (SPECT) scan for dopamine transport in the brain and where dopamine is inhibited
c. DSM-V: Neurocognitive disorders with Lewy bodies. Core characteristics: Insidious onset and gradual decline.

32
Q

DSM-V: Neurocognitive disorders with Lewy bodies. Diagnostic features:

A

i. Fluctuating cognition
ii. Visual hallucinations: Vivid, well formed, detailed
iii. Spontaneous parkinsonism starting after cognitive decline
iv. REM sleep disorders: “My dream is more real than your reality.”
v. Overly sensitive to antipsychotic medicines (explanation – many antipsychotics decrease dopamine worsening underlying pathophysiology of Lewy body dementia)

33
Q

usual age of onset for Lewy body dementia

A

~ 50 years old
**On average, individual will live 4-8 years from diagnosis (~ age 50+) to death.

34
Q

what does both Alzheimers and Lewy body lack?

A

they both lack dopamine, but it impacts different areas of the brain

35
Q

compare and contrast Lewy body dementia and Parkinson disease

A
  • Lewy body dementia: cognitive changes precede motor symptoms
  • Parkinson disease: motor symptoms precede cognitive changes
36
Q

what is the classification of frontotemporal dementia?

A

Heterogeneous condition associated with degeneration of the frontal and temporal lobes.

a. Behavioral variant FTD (bvFTD)
b. Primary progressive aphasia:
i. Semantic variant
ii. Non-fluent variant

37
Q

pathophysiology of frontotemporal dementia

A

Tau inclusions and neurofibrillary tangles damage and destroy cells of the frontal and temporal lobe. Dead neurons clump together to form Pick cells. Localized decreased brain volume, deep sulci and narrow gyri.

38
Q

diagnosis of FTD

A

a. History and physical: Similar to Alzheimer disease.
b. Based on clinical presentation/manifestations.

39
Q

usual age of onset for FTD

A

Insidious onset, gradual decline often starting age 45+, mean survival ~ 5 years.

40
Q

clinical presentation/manifestations: Behavioral variant FTD (4)

A
  • Loss of executive function:
    Problems planning and sequencing (thinking through which steps come first, second, and so on)
    Difficulty prioritizing tasks or activities.
  • Perseveration/compulsiveness; Hyperorality: Repeating the same activity or saying the same word over and over.
  • Disinhibition: Acting impulsively or saying or doing inappropriate things without considering how others perceive the behavior
  • Apathy/inertia; loss of sympathy/empathy: Becoming disinterested in family or activities they used to care about.
41
Q

clinical presentation/manifestations: Semantic version PPA (primary progressive aphasia)

A

Fluency of speech intact with impaired single word comprehension. May cross over to poor/indistinct representations in drawn objects

e.g. “Would you like a hamburger?”
“What’s a hamburger?” “Draw a bird.” Drawn picture lacks detail of beak, wings, and tail.

42
Q

clinical presentation/manifestations: Non-fluent version PPA (primary progressive aphasia)

A

minimal speech with comprehension intact

43
Q

define delirium

A

A syndrome characterized by an acute change in attention, awareness and cognition. Delirium commonly occurs in hospitalized patients with premorbid factors and precipitating events (presenting illness or hospitalization)

**it is acute not insidious

44
Q

State four major mechanisms of delirium.

A
  1. Neuronal networks disrupted: Increased brain vulnerability and decreased brain resilience. Age and neurological diseases (acute or chronic)
  2. Vascular dysfunction and metabolic insufficiency: Brain energy requirements not met: Impaired oxygen and glucose delivery and/or increased cerebral metabolic demand.
    13
  3. Inflammatory effect of glial cells: Pathogen associated (PAMP) or damage associated molecular patterns (DAMP) initiate widespread inflammatory response and tissue damage.
  4. Drugs & stressors → neurotransmitter imbalance
45
Q

List the five DSM-V domains for delirium

A

a. disturbance in attention (i.e., reduced ability to direct, focus, sustain, and shift attention)
and awareness (reduced orientation to the environment).
b. disturbance develops over a short period of time (usually hours to a few days), represents a change from baseline attention and awareness, and fluctuates in severity during the course of a day.
c. additional disturbance in cognition (e.g. memory deficit, disorientation, language, visuospatial ability, or perception).
d. disturbances in criteria a and c are not better explained by a pre-existing, established or evolving neurocognitive disorder and do not occur in the context of a severely reduced level of arousal, such as coma.
e. evidence from the history, physical examination or laboratory findings that the disturbance is a direct physiological consequence of another medical condition, substance intoxication or withdrawal, or exposure to a toxin, or is due to multiple etiologies.

46
Q

what are prevention models for delirium?

A
  1. hospital elder life program (HELP)
  2. ABCDEF bundle
47
Q

what is hospital elder life program?

A

A multi-disciplinary team approach that addresses the following risks for delirium in hospitalized, older adults: visual and hearing impairment, immobility, disorientation, sleep deprivation (non-pharmacological) and dehydration.
visual and hearing impairment,
Outcomes: Reduction in delirium (5%) and fewer falls